Running title: Calcium entrance stimulates the TGF-β1-induced PPi export
Transforming growth factor (TGF)-β1 stimulates extracellular PPi (ePPi) generation and promotes chondrocalcinosis, which also occurs secondary to hyperparathyroidisminduced hypercalcemia. We previously demonstrated that ANK was up-regulated by TGF-β1 activation of extracellular signalregulated kinase (ERK)1/2 and Ca 2+ -dependent protein kinase C (PKC)α. Thus, we investigated mechanisms by which calcium could affect ePPi metabolism, especially its main regulating proteins ANK and Plasma Cell membrane protein-1 (PC-1). We stimulated articular chondrocytes with TGF-β1 under extracellular (eCa 2+ ) or cytosolic Ca 2+ (cCa 2+ ) modulations. We studied ANK, PC-1 expression (quantitative RT-PCR, western blotting), ePPi levels (radiometric assay) and cCa 2+ input (fluorescent probe). Voltage-operated Ca 2+ -channels (VOC) and signaling pathways involved were investigated with selective inhibitors. Finally, Ank promoter activity was evaluated (gene reporter).
TGF-β1 elevated cCa
2+ and ePPi levels (by upregulating Ank and PC-1 mRNA/proteins) in an eCa 2+ dose-dependent manner. TGF-β1 effects were suppressed by cCa 2+ chelation or L-and T-VOCs blockade, while being mostly reproduced by ionomycin. In the same experimental conditions, the activation of Ras, the phosphorylation of ERK1/2 and PKCα, or the stimulation of Ank promoter activity were affected similarly. Activation of Specific Protein 1 (SP1) and Ets-like protein-1 (ELK-1) transcription factors supported the regulatory role of Ca 2+ . SP1 or ELK-1 overexpression, or blockade experiments demonstrated a major contribution of ELK-1, which acted synergistically with SP1 to activate Ank promoter in response to TGF-β1. TGF-β1 promotes input of eCa 2+ through opening of L-and T-VOCs, to potentiate ERK1/2 and PKCα signaling cascades, resulting in an enhanced activation of Ank promoter and ePPi production in chondrocyte.
The balance between extracellular inorganic pyrophosphate (ePPi) and extracellular inorganic phosphate (ePi) is critical for homeostasis of articular cartilage. Indeed, an increase in ePPi supports calcium pyrophosphate dihydrate crystals (CPPD) depositions responsible for articular chondrocalcinosis (CCA) (1) . Production of ePPi by articular chondrocytes is dependent on PC-1 (also known as ENPP1), an ecto-enzyme which produces ePPi from nucleotide triphosphates (2) , and on the transporter ANK which exports PPi across the cell membrane (3) . Although ePPi level can be controlled by tissue non-specific alkaline phosphatase (TNAP), which hydrolyzes ePPi into ePi, no expression of this enzyme was detected in healthy articular cartilage, comparatively to osteoarthritic cartilage (4) . Therefore, CPPD formation only depends on the expression level of PC-1 and ANK in mature articular cartilage. Transforming growth factor (TGF)-β1 is a wellknown inducer of ePPi production by articular chondrocytes (1) . We demonstrated previously that ANK was the major contributor of this TGF-β1-induced ePPi production meanwhile PC-1 played a minor role (5) . Furthermore, these effects of TGF-β1 relied on an ERK1/2-calciumdependent protein kinase C (PKC) signaling mechanism, which was independent from Smad activation. TGF-β1 levels were also described to be gradually increased in a rat model of hyperparathyroidism consisting in a daily injection of parathyroid hormone (PTH) for three months (6) . PTH levels are classically elevated in patients with hyperparathyroidism, and an increase in circulating PTH was also reported in patients with idiopathic CPPD depositions (7) . Altogether, these observations support a potential role for TGF-β1 in the formation of CPPD crystals formation in the context of primary hyperparathyroidism. CCA linked to hyperparathyroidism reaches the prevalence of 21% (8) . Besides development of CCA, patients with hyperparathyroidism have a chronic elevation of free calcium levels in their extracellular fluids. Although no direct link was reported between hypercalcemia and CCA (9) , a very recent study demonstrated that patients with familial hypocalciuric hypercalcemia developed CCA (10) . The modus operandi by which calcium may influence CPPD formation remains however unclear, and is then worth to be studied. The higher calcium levels found in patients with hyperparathyroidism could influence chondrocytes metabolism by stimulating calcium input through voltage-operated channels (VOCs). Indeed, several VOCs were described to be expressed in chondrocytes, such as N-VOCs (11), L-and T-VOCs (12) . Another possible mechanism could be related to the activation of the calcium-sensing receptor (CaSR), a G protein coupled receptor (13) . Furthermore, calcium was described to stimulate the activity of the transcription factor Sp1, which increased the basal transcription of the beta1,3-glucuronosyltransferase I (GlcAT-I), a key enzyme responsible for the completion of cartilage proteoglycans (14) . Interestingly, Sp1 activity was also shown to be implicated both in the TGF-β1-induced expression of tissue inhibitor of metalloproteinase-3 (15) and GlcAT-I (16) in chondrocytes. These findings suggest a possible regulatory interplay between calcium and TGF-β1 through the Sp1 transcription factor, that could result possibly in CPPD crystals deposition in articular cartilage. The present work investigated whether the variation in either extracellular or cytosolic calcium levels could influence the stimulating effects of TGF-β1 on ePPi production by articular chondrocytes. A particular care was taken in deciphering the contribution of VOCs and the signaling events regulating the expression of the main ePPi regulating genes PC-1 and especially Ank, with a study of its promoter region.
EXPERIMENTAL PROCEDURES
Chondrocyte isolation and culture-Articular cartilage was obtained from 6 weeks-old healthy male Wistar rats (130-150 g) killed under dissociative anesthesia [ketamine (Mérial, France) and acepromazine (Sanofi-Aventis, France)] in accordance with our Institutional local ethics committee and the national animal care guidelines. Cartilage pieces were dissected aseptically from femoral head caps and chondrocytes were obtained by sequential digestion with pronase and collagenase B (Roche Applied Science, France) as described previously (17) . Cells were washed twice in PBS and cultured to confluence in 75-cm 2 flasks at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were maintained in calcium-free DMEM (Invitrogen, France), supplemented with 1.25 mM of CaCl 2 (Sigma, France), L-glutamine (2 mM), gentamicin (50 µg/ml), amphotericin B (0.5 µg/ml), and 10% heat-inactivated FCS (Invitrogen). Unless specified, we used first passaged chondrocytes plated at 4.10 5 cells/well in six-well plates throughout the study. Except the dose-ranging studies on eCa 2+ level, experiments were performed in calcium-free DMEM, supplemented with 1.25 mM Ca 2+ to mimick the physiological free circulating Ca 2+ levels. Chemicals-All chemical reagents were from Sigma, unless specified. All the compounds used in this study were dissolved in DMSO (final concentration 0.1%), used as vehicle in control experiments. At the concentrations used, no cytotoxicity of either compound was detected in MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay after 72 h of exposure (data not shown). Final concentrations were chosen after preliminary experiments demonstrating the selectivity of signal transduction inhibitors (Immunoblotting of the phosphorylation level of the concerned signaling pathway; data not shown). TGF-β1 (PeproTech, France) was used at a final concentration of 10 ng/ml throughout the study. RNA extraction and Reverse-transcription-Total RNA was isolated using RNeasyplus mini kit ® (Qiagen, France), which allows total removal of genomic DNA (gDNA) with an on-column DNA elimination step. Five hundred ng of total RNA were reverse-transcribed for 90 minutes at 37°C in a 20 µl reaction mixture containing 2.5 mM dNTP, 5 µM random hexamer primers, 1.5 mM MgCl 2 , and 200 U Moloney Murine Leukemia Virus reverse transcriptase (Invitrogen). cDNAs production was performed in a Mastercycler gradient thermocycler (Eppendorf, France).
Real time quantitative PCR (RT-qPCR)-
To check our chondrocyte phenotype and measure mRNA levels of target genes, RT-qPCR was performed using the Lightcycler® (Roche Applied Science) technology. PCR was done with SYBRgreen master mix system (Qiagen). The gene-specific primer pairs are provided in Table 1 . Melting curve was performed to determine the melting temperature of the specific PCR products, and after amplification the product size was checked on a 1% agarose gel stained with ethidium bromide (0.5 µg/ml). Each run included positive and negative reaction controls. The mRNA level of the gene of interest and of S29, chosen as housekeeping gene, was determined in parallel for each sample. The S29 gene, which codes for a ribosomal protein, was shown previously to be invariable in TGF-β1-challenged chondrocytes (5) . Quantification was determined using a standard curve made from a purified PCR product for each gene tested, with concentrations ranging from 10 -3 to 10 -9 ng/µl. Results were expressed as the ratio of the mRNA level of each gene of interest over S29 gene. Western blot analysis-Chondrocytes were harvested and lysed in 1X Laemmli buffer. Samples were run on SDS-PAGE (10%) and transferred onto a polyvinylidene fluoride membrane (Immobilon TM , Waters, France). After 2 h in blocking buffer (TBS-0.1% Tween (TBST) supplemented with 5% non-fat dry milk), membranes were washed three times with TBST and incubated overnight at 4°C with primary antibodies. The antibodies against ANK and PC-1 (Eurogentec, France) were used at 1/500 dilution as we described previously (5, 18) . Antibodies directed against native and phosphorylated ERK1/2 and PKCα (Cell Signaling Technology, France), as well as antibodies against native (Santa Cruz Biotechnology, Germany) and phosphorylated ELK-1 (Millipore, France) were used at 1/500. Antibodies against total (Millipore) and phosphorylated SP1 (Abcam, France) were used at 1/1000, and the anti β-actin (Sigma) at 1/4000. After three washings with TBST, each blot was incubated for 1 h at room temperature with antirabbit IgG conjugated with HRP (Cell Signaling Technology) at 1/2000 dilution in blocking buffer. After four washings in TBST, protein bands were detected by chemiluminescence with the Phototope Detection TM system according to manufacturer's recommendations (Cell Signaling Technology). Band intensities were quantified by densitometry with the Gnome TM computerized image processing system (Syngene, Cambridge, UK). Extracellular PPi (ePPi) assays-ePPi levels were measured in culture supernatants, using the differential adsorption between UDP-(6-3 H) glucose (Perkin-Elmer, France), and its reaction product 6-phospho-(6-3 H) gluconate on activated charcoal, as previously described (19) . The standards, ranging from 10 to 400 pmol of PPi, were included in each assay. After adsorption of the reaction mixture on charcoal, and centrifugation at 16000 g for 10 minutes, 100 µl of the supernatant were counted for radioactivity in 5 Ank promoter cloning in pGL3-Human Ank promoter sequence (GenBank accession number AC016575) was cloned from a mix of genomic DNA from different organs (brain, heart, liver, kidney) (Clinisciences, France) in the pGL3 luciferase reporter vector (Promega, France), using the KpnI and XhoI sites. Primers used for the amplification are described in Table 1 . We cloned a -720 bp fragment containing two putative Sp1 responsive elements (RE) (-125/15 bp and -532/22 bp), and a -2715 bp fragment containing the Sp1 REs, and one putative Elk-1 RE (-1860/44 bp). These REs were identified using TFSearch 1.3 algorithm (21) .
Plasmid
ElectroporationCells were electroporated as previously described (5) using the Chondrocyte Nucleofector ® Kit (Lonza, France) according to manufacturer's protocol, with the Nucleofector ® (Lonza) program U-28. In one set of experiments, we transfected either the -720 bp or the -2715 bp Ank promoter fragment (1 µg/3.10 5 cells) in chondrocytes exposed or not to TGF-β1. In another set of experiments, cells were co-transfected with either one of these constructs, along with 1 µg/3.10 5 cells of either pCMV-Sp1 (overexpressing wild-type human SP1 protein), or pCMV-Elk-1 (overexpressing wild-type human ELK-1 protein), or both vectors. These constructs were a generous gift from Dr. M. Ouzzine (UMR7561 CNRS-Nancy University (14) ). In each experiment, chondrocytes were transfected with pTK-RL expressing Renilla luciferase (500 ng/3.10 5 cells) to normalize the results. Plasmid pmaxGFP TM (Lonza), encoding a GFP was used to assess transfection efficiency. Reporter Gene Assay-Luciferase activities were measured using Dual-Luciferase Reporter Assay TM kit (Promega). Briefly, chondrocytes electroporated with reporter gene constructs were stimulated or not for 48 h with TGF-β1. After two washings in PBS, cells were lysed in 1X passive lysis buffer for 15 minutes at RT. Cell lysate was placed in LAR II (firefly luciferase substrate) and luminescence was read with Sirius luminometer (Berthold technologies). Afterwards, Stop & Glo reagent (renilla luciferase substrate) was added to the sample and luminescence was acquired by the same way. Results were expressed as the mean ratio of firefly/renilla luciferase activity, in fold induction over control. Statistical analysis-Results are expressed as the mean ± S.D. of at least three independent assays. Comparisons were made by ANOVA, followed by Fisher's t post-hoc test, using the Statview™ 5.0 software (SAS Institute Inc). A value of p < 0.05 was considered significant.
RESULTS

Effects of eCa 2+ levels on TGF-β1-stimulated metabolism of PPi and calcium mobilization in chondrocytes.
Firstly, we confirmed that the articular phenotype of chondrocyte was maintained throughout the study. Indeed, a strong expression of type II collagen was observed, whereas collagens type I and X, Runx2 and TNAP remained undetectable (data not shown). This confirmed our previous report (5) , and underlined that no dedifferentiation nor switch towards hypertrophy occurred in our culture conditions. To determine the influence of eCa 2+ level on the TGF-β1-stimulated metabolism of ePPi, chondrocytes were incubated in calcium-free DMEM containing 1% FCS, which was supplemented or not with 1.25, 2.5 or 5 mM of CaCl 2 for 24 h. Then, cells were exposed to TGF-β1 for either 24 h (mRNA expression), 48 h (protein level) or 72 h (ePPi production). Of note, all results were analyzed in comparison to the "physiological" concentration of 1.25 mM eCa 2+ . Basal ePPi level was reduced from 65 to 42 pmol/µg of protein (-35%) in the calcium-free medium, while being increased to 89 pmol/µg of protein (1.4-fold) at 5 mM eCa 2+ ( Figure 1A ). TGF-β1 increased the ePPi production from 65 to 274 pmol/µg of protein (4.2-fold) at 1.25 mM eCa 2+ . This effect was limited to 94 pmol/µg of protein (2.3-fold) in absence of eCa 2+ , while increasing gradually with eCa 2+ to peak at 389 pmol/µg of protein (4.4-fold) at 5 mM eCa 2+ .
Compared to the 1.25 mM eCa 2+ condition, basal Ank mRNA level (evaluated by RT-qPCR) was reduced from 3.8 to 0.8 (-79%) in the absence of eCa 2+ , while PC-1 expression was decreased from 2.5 to 1.2 (-52%) ( Figure 1B ). Conversely, supplementation of culture medium with 5 mM eCa 2+ up-regulated the expression of Ank from 3.8 to 5.4 (1.4-fold) and of PC-1 from 2.5 to 5 (2-fold) ( Figure 1B ). TGF-β1 increased Ank and PC-1 mRNA expression to 19.2 (5-fold) and 9.6 (3.8-fold) respectively at 1.25 mM eCa 2+ . In the absence of eCa 2+ , TGF-β1 elevated the expression of Ank only from 0.8 to 2.1 (2.6-fold) and of PC-1 from 1.2 to 2.5 (2.1-fold). However, the effect of TGF-β1 reached 32 (8.4-fold) for Ank and 22.5 (9-fold) for PC-1 at 5 mM eCa 2+ . Interestingly, the articular phenotype of chondrocytes was neither affected by changes in eCa 2+ levels, nor by TGF-β1 challenge, since type I and type X collagen remained undetectable whereas a high mRNA level of type II collagen was maintained (data not shown). Western blot analysis ( Figure 1C ) confirmed the influence of eCa 2+ on the inducing effect of TGF-β1 on Ank and PC-1 mRNA levels, since the progressive increase in eCa 2+ boosted the TGF-β1 up-regulation of ANK and PC-1 protein levels. Finally, we checked whether TGF-β1 and/or eCa 2+ could initiate calcium mobilization in chondrocytes. For that goal, cytosolic calcium (cCa 2+ ) level was evaluated in cells exposed for 24 h to the different eCa 2+ concentrations, before being challenged or not with TGF-β1. Per se, eCa 2+ variation was unable to modify cCa 2+ level after 1 min of exposure ( Figure 1D ). However, after 5 min of exposure, cCa 2+ level were increased from 0.5 to 0.8 RFU (1.6-fold) and from 0.5 to 1 RFU (2-fold) in cells incubated with either 2.5 or 5 mM eCa 2+ , respectively ( Figure 1D ). After 1 min, TGF-β1 was ineffective in the absence of eCa 2+ , whereas it increased cCa 2+ level from 0.5 to 2.7 RFU (5.4-fold) at 1.25 mM eCa 2+ ( Figure 1D ). At higher eCa 2+ concentrations, this increase in cCa 2+ level was emphasized to 3.6 RFU (7.2-fold, at 2.5 mM) and 5 RFU (10-fold, at 5 mM). Interestingly, after 5 min of exposure to the same culture conditions, TGF-β1 remained ineffective in the absence of eCa 2+ , while producing lower effects than at 1 min for the other eCa 2+ concentrations ( Figure 1D ). This was consistent with the time-course analysis showing that TGF-β1 influence was maximal after 1 min (data not shown).
Taken together, these data demonstrate that the stimulating effect of TGF-β1 on Ank and PC-1 was enhanced by eCa 2+ in a dose-related fashion, which suggests a key regulatory role for calcium on the modulation of ePPi metabolism by TGF-β1 in chondrocyte.
Effect of selective Ca 2+ -VOCs blockers and CaSR agonist on TGF-β1-activated metabolism of PPi and calcium mobilization in chondrocytes.
We next investigated the mechanisms involved in the cCa 2+ mobilization and stimulation of ePPi metabolism by TGF-β1. For that goal, we examined the consequence of a 1 h preincubation of chondrocytes with either a selective CaSR agonist GdCl 3 (100 µM), or the following selective VOCs blockers (Merck, Darmstadt, Germany): ω-Agatoxin (1 µM, for P/Q-type), ω-Conotoxin (1 µM, for N-type), Lercanidipin (10 µM, for L-type) and NiCl 2 (50 µM, for a selective blockade of T-VOCs (22)). Their effects were then assessed after either 24 h (mRNA expression), 48 h (protein level) or 72 h (ePPi production) of stimulation with TGF-β1, in the presence of 1.25 mM eCa 2+ . The basal ePPi production was unaffected by any of the compounds listed above (Figure 2A) . Moreover, neither activation of CaSR, nor blockade of N-VOCs affected the TGF-β1-stimulated ePPi production, whereas ω-Agatoxin slightly decreased it from 274 to 235 pmol/µg of protein (-14%) (Figure 2A ). In contrast, Lercanidipin and NiCl 2 markedly diminished the TGF-β1 effect to 162 pmol/µg of protein (-41%) and 93 pmol/µg of protein (-66%) respectively (Figure 2A ). In accordance with these findings, none of these compounds modified the basal mRNA expression of Ank and PC-1 ( Figure 2B ). Once again, neither GdCl 3 nor ω-Conotoxin modulated the stimulating effect of TGF-β1 on Ank and PC-1 mRNA levels, whereas P/QVOCs blockade by ω-Agatoxin diminished it from 19.2 to 15.3 (-20%) for Ank and from 9.6 to 7.9 (-18%) for PC-1 ( Figure 2B ). More importantly, blockade of L-or T-VOCs by Lercanidipin or NiCl 2 reduced the impact of TGF-β1 on Ank mRNA level to 9.9 (-49%) and 6.6 (-66%) respectively ( Figure 2B) . Similarly, PC-1 expression was reduced to 6.1 (-36%) and 5 (-48%) respectively. Western blot analysis ( Figure 2C ) corroborated the assets obtained at the mRNA level, since only Lercanidipin and NiCl 2 significantly reduced the increase in ANK and PC-1 protein level induced by TGF-β1 ( Figure 2C ), while GdCl 3 and ω-Conotoxin remained ineffective (data not shown). Finally, to evaluate the possible involvement of these VOCs in the TGF-β1-induced calcium mobilization, we measured cCa 2+ level in the same experimental conditions as above. None of the compounds affected the basal cCa 2+ level ( Figure 2D ). Interestingly, only the blockade of L-and T-VOCs lowered the TGF-β1-stimulated calcium mobilization, from 2.7 RFU to 1.7 RFU (-37%) and 1.1 RFU (-60%) respectively ( Figure  2D ). Although ω-Agatoxin displayed a moderate inhibitory effect on TGF-β1-stimulated metabolism of ePPi, it remained ineffective on cCa 2+ level. These results demonstrate a major role for calcium entry through L-and T-type VOCs in the modulation of the TGF-β1 stimulating effect.
Effect of calcium chelation or release from internal stores on TGF-β1-induced metabolism of PPi and Ca
2+ mobilization in chondrocytes. To evaluate the respective contribution of cCa 2+ level and calcium located in internal stores on the stimulating effect of TGF-β1 on ePPi production, we examined the consequence of a 1 h pre-incubation of cells with three following compounds (Merck): a calcium chelator, BAPTA-AM (1 µM), a calcium ionophore, ionomycin (1 µM) and an inhibitor of phospholipase C (PLC)-dependent calcium release from endoplasmic reticulum, U73122 (10 µM). Their effects were then assessed after either 24 h (mRNA expression), 48 h (protein level) or 72 h (ePPi production) of stimulation with TGF-β1, in the presence of 1.25 mM eCa 2+ . None of the compound listed above modified the basal ePPi production ( Figure 3A) . Moreover, PLC inhibition did not affect the TGF-β1-stimulated production of ePPi ( Figure 3A) . Interestingly, while BAPTA significantly decreased the TGF-β1-stimulated ePPi level from 274 to 145 pmol/µg of protein (-49%), ionomycin raised it to 442 pmol/µg of protein (1.6-fold). None of the compounds significantly modified the basal mRNA expression of Ank and PC-1 ( Figure 3B ). Chelation of cCa 2+ by BAPTA reduced the effect of TGF-β1 from 19.2 to 7.9 (-59%) for Ank and from 9.6 to 4.9 (-49%) for PC-1 mRNA levels. In contrast, cCa 2+ elevation induced by ionomycin boosted the effect of TGF-β1 from 19.2 to 36.4 (1.9-fold) for Ank and from 9.6 to 17.8 (1.9-fold) for PC-1. Once again, U73122 remained ineffective ( Figure 3B ). Western blot analysis ( Figure 3C) confirmed the opposite influence of BAPTA and ionomycin on the inducing effect of TGF-β1 on ANK and PC-1 protein levels ( Figure 3C ). Interestingly, although ionomycin alone failed to modify Ank mRNA level, it strongly induced ANK expression. This apparent discrepancy may come from the ability of ionomycin to stabilize mRNA, as demonstrated previously for the interleukin-3 transcript (23), therefore allowing an increase in the translation step. Finally, neither the basal nor the TGF-β1-induced increase in cCa 2+ level was affected by PLC inhibition ( Figure 3D ). In contrast, even though BAPTA did not modify the basal cCa 2+ level, it lowered the TGF-β1-induced influx from 2.7 RFU to 1 RFU (-63%). In an opposite fashion, ionomycin increased the basal cCa 2+ level to 3.3 RFU (6.6-fold), and potentiated the stimulating effect of TGF-β1 to 5.5 RFU (1.7-fold) ( Figure  3D ). Taken together, these results demonstrate that an increase in cCa 2+ , independent of PLC-dependent calcium release from the endoplasmic reticulum, is critical for the stimulating effect of TGF-β1 on ePPi metabolism. To evaluate the influence of calcium on the signaling pathways activated by TGF-β1 and implicated in the regulation of ePPi metabolism, we assessed, by immunoblotting, the activation of ERK1/2 and Ca 2+ -dependent PKC. For that purpose, chondrocytes were challenged with TGF-β1, for 5 (PKC) or 15 (ERK) minutes, as described elsewhere (5) . During these experiments, we modulated either the eCa 2+ level or modified the eCa 2+ entrance (with the only efficient VOCs blockers, Lercanidipin and NiCl 2 ) as well as the cCa 2+ level (using BAPTA and ionomycin). We completed this study by evaluating the consequence of ERK1/2 or PKCα inhibition on the increase in ANK and PC-1 protein level induced by high eCa 2+ levels. To that goal, cells were pre-incubated for 1 h of with the following selective inhibitors (Merck): PD98059 (10 µM, a MEK 1 inhibitor that prevents ERK1/2 activation) or Gö6976 (5 µM, a selective calcium-dependent PKC inhibitor). Then, ANK and PC-1 protein levels were determined after additional 48 h incubation in culture medium containing either 1.25 or 5 mM Ca 2+ . As shown in Figure 4A , eCa 2+ alone was sufficient to stimulate the phosphorylation cascades, from 1.25 mM for ERK1/2 and 2.5 mM for PKCα. Interestingly, although TGF-β1 was able to induce ERK1/2 phosphorylation in absence of calcium, this activation increased gradually with eCa 2+ level. Likewise, the phosphorylation of PKCα by TGF-β1 was also related to eCa 2+ level ( Figure 4A ). When chondrocytes cultured at 1.25 mM Ca 2+ were pre-incubated with L-VOCs blocker Lercanidipin, the TGF-β1-induced ERK1/2 phosphorylation was weakened, while the activation of PKCα was totally suppressed ( Figure 4B ). The same results were observed for T-VOCs blockade by NiCl 2 , however with a more marked reduction of ERK1/2 phosphorylation. As shown in Figure 4C , BAPTA totally prevented ERK1/2 and PKCα phosphorylation by TGF-β1. In contrast, ionomycin was sufficient per se to enhance the basal phosphorylation of PKCα and ERK1/2. However, in response to TGF-β1, only the phosphorylation of PKCα was enhanced by the cCa 2+ burst, suggesting that activation of the ERK1/2 pathway was still maximal under ionomycin challenge. As demonstrated in Figure  4D , the increase in ANK and PC-1 protein levels by 5 mM Ca 2+ was almost totally suppressed by both PD98059 and Gö6976. Finally, to assess how calcium input could regulate TGF-β1 signaling, we checked the activation status of Ras, which was previously shown to be activated secondary to an increase in cCa 2+ level (24) . To that goal, chondrocytes at 90% confluency were incubated in calcium-free DMEM containing 1% FCS, which was supplemented or not with 1.25 mM eCa 2+ for 24 h. Then, cells cultured without eCa 2+ were pre-incubated for 1 h with vehicle, while cells exposed to 1.25 mM eCa 2+ were preincubated either with vehicle or calcium modulators (i.e. Lercanidipin, NiCl 2 , or BAPTA). Afterwards, chondrocytes were exposed to TGF-β1 for 5 min, and the amount of Ras-GTP was estimated in total cell lysates. As shown in Figure 4E , no increase in Ras-GTP level was detected in cells stimulated with TGF-β1 in the absence of eCa 2+ . In contrast, in the presence of 1.25 mM eCa 2+ , TGF-β1 induced a 2.8-fold increase in Ras-GTP level (from 1.1 to 3.1 RLU). Interestingly, the blockade of VOCs, of L-type by lercanidipin and T-type by NiCl 2 , reduced this effect, from 3.1 to 2.2 RLU (-43%) and 1.4 RLU (-85%) respectively ( Figure 4E ). In these experimental conditions, BAPTA reduced the TGF-β1-induced increase in Ras-GTP level to those observed in the absence of eCa 2+ . These results demonstrate that the stimulatory effect of TGF-β1 on Ras, ERK1/2 and PKCα activation is critically regulated by eCa 2+ entry. ERK1/2 and PKCα directly contribute to the increase in ANK and PC-1 protein level provoked by high calcium levels.
Contribution of Sp1 to the regulatory role of calcium on the chondrocyte response to TGF-β1. Since Sp1 was reported to relay the effect of TGF-β1, we assessed its possible role in the modulation of TGF-β1-stimulated metabolism of ePPi in regard to calcium. To that goal, we investigated the influence of eCa 2+ level on SP1 protein expression by immunoblotting. Thus, chondrocytes were challenged with TGF-β1 for 24 h while modulating, either the eCa 2+ level, the eCa 2+ entrance (pre-incubation 1 h with the efficient VOCs blocker, Lercanidipin and NiCl 2 ) or the cCa 2+ level (1 h of pre-exposure with BAPTA or ionomycin). We completed this study using chondrocytes either pre-treated for 1 h with WP631 (Merck, 1 µM, inhibitor of the DNAbinding ability of SP1), or transfected with a control siRNA or a mix of siRNA targeting Sp1 (Santa Cruz Biotechnology, 10 nM). We then exposed cells to TGF-β1 for either 24 h (mRNA expression), 48 h (protein level) or 72 h (ePPi production), in the presence of 1.25 mM eCa 2+ . As shown in Figure 5A , a physiological eCa 2+ level alone was sufficient to elevate SP1 protein level compared to the no-calcium condition. Interestingly, although TGF-β1 was able to induce SP1 expression by itself, this effect increased gradually with eCa 2+ concentration. In chondrocytes pre-treated with Lercanidipin or NiCl 2 , the TGF-β1-induced increase of SP1 was totally suppressed, as was also the case for BAPTA ( Figure 5A ). Ionomycin increased the total expression of SP1 by itself, but blunted the stimulatory effect of TGF-β1 on this protein ( Figure 5A ). When we assessed the phosphorylation of SP1 after 30 min of stimulation, we showed that TGF-β1-induced SP1 phosphorylation ( Figure 5A ). This activation of SP1 was totally suppressed by BAPTA. In contrast, ionomycin enhanced both the basal and the TGF-β1-induced increase in SP1 phosphorylation ( Figure 5A ). Neither WP631, nor Sp1 silencing modulated the basal ePPi production ( Figure 5B ). In contrast, WP631 significantly decreased the TGF-β1-stimulated ePPi production from 274 to 99 pmol/µg of protein (-64%). Similarly, Sp1 silencing reduced the TGF-β1-induced ePPi production to 87 pmol/µg of protein (-68%) ( Figure 5B ). Once again, neither WP631, nor Sp1 silencing modified the basal mRNA expression of Ank and PC-1 ( Figure 5C ). However, WP631 reduced the TGF-β1 induction from 19.2 to 7.5 (-61%) for Ank and from 9.6 to 5 (-48%) for PC-1 mRNA expression. Similarly, Sp1 silencing decreased the TGF-β1-induced Ank expression to 5.7 (-70%), as well as PC-1 level to 4.8 (-50%). Western blot analysis ( Figure 5D ) validated the efficiency of Sp1 silencing, and confirmed its major impact on the stimulatory effects of TGF-β1 on ANK and PC-1 protein level. These results show that Sp1 contributes to the modulatory influence of calcium on the TGF-β1-induced production of ePPi.
Effect of a selective inhibition of TGF-β1-induced signaling pathways on cCa 2+ level and transcription factors activation.
To evaluate further the respective role of calcium mobilization and TGF-β1 in the activation of signaling pathways, we assessed the consequence of a selective inhibition of ERK1/2 and PKCα. Firstly, cells were pre-incubated for 1 h in the presence of 1.25 mM eCa 2+ with one of the following selective inhibitors: PD98059, Gö6976 and WP631. Then, cCa 2+ levels cells were determined after 1 min of stimulation with TGF-β1. As shown in Figure 6A , neither the basal nor the TGF-β1-induced increase in cCa 2+ level were affected by the inhibition of either signaling pathway. Secondly, we assessed whether inhibition of ERK1/2 and PKCα activation could alter SP1 expression and phosphorylation status, as cross-talks between ERK1/2 and PKCα (25) , and ERK2 and SP1 (26) pathways have been reported. For that purpose, in the same pre-incubation conditions as above, chondrocytes were stimulated with TGF-β1 for 30 min (SP1 phosphorylation) or 24 h (total SP1 expression level), in the presence of 1.25 mM eCa 2+ . As demonstrated in Figure 6B , the TGF-β1-induced phosphorylation of SP1was totally suppressed by MEK1 inhibition (PD98059 treatment), while Gö6976-induced blockade of PKCα activation had no effect. Thirdly, we assessed whether the blockade of ERK1/2 and PKCα activation could influence the phosphorylation of the transcription factor ELK-1, described as a downstream effector of ERK1/2 activation (27) . To that goal, in the same pre-incubation conditions as above, ELK-1 phosphorylation was evaluated after 30 min of stimulation of chondrocytes with TGF-β1 in the presence of 1.25 mM eCa 2+ . As seen in Figure  6C , the TGF-β1-induced phosphorylation of ELK-1 was totally suppressed by PD98059 treatment, while Gö6976-induced blockade of PKCα activation remained ineffective. These results demonstrated that TGF-β1-induced mobilization of cCa 2+ is an early event independent of the activation of ERK1/2, PKCα and SP1. Moreover, TGF-β1 is responsible for a ERK1/2-dependent activation of SP1 and ELK-1, independently of PKCα activation.
Regulation of Ank promoter by cCa 2+ level, Sp1 and Elk-1 in chondrocytes.
As we demonstrated previously that Ank contributed much more than PC-1 to the TGF-β1-induced production of ePPi by chondrocytes (5), we therefore focused our investigation on the Ank promoter sequence. For that purpose, we challenged chondrocytes, electroporated with either the -720 bp or the -2715 bp Ank promoter construct ( Figure 7A) , with TGF-β1 for 48 h in the presence of 1.25 mM eCa 2+ , while modulating the eCa 2+ entrance (pre-treatment 1 h with Lercanidipin or NiCl 2 ) or the cCa 2+ level (1 h of pre-exposure with BAPTA or ionomycin). As depicted in Figure 7B , neither the VOCs blockade nor the dramatic changes in cCa 2+ modified the basal Firefly/Renilla ratio in chondrocytes transfected with the -720 bp Ank construct. In contrast, TGF-β1 increased the luciferase activity by 1.3-fold. This weak induction was totally suppressed by the blockade of VOCs, as well as by cCa 2+ chelation. In contrast, ionomycin increased the effect of TGF-β1 from 1.3-to 1.6-fold. In chondrocytes electroporated with the -2715 bp fragment, the basal Firefly/Renilla ratio was increased by 2.7-fold by TGF-β1 ( Figure 7B ). When L-and TVOCs were blocked, the stimulatory effect of TGF-β1 was reduced from 2.7-to 2-and 1.3-fold respectively. Similarly, BAPTA decreased the TGF-β1 effect from 2.7-to 1.3-fold. In contrast, ionomycin alone was sufficient to induce a 1.4-fold activation of Ank promoter, but also boosted the TGF-β1-stimulated activation from 2.7-to 4.4-fold ( Figure 7B ). Besides highlighting the regulatory role of cCa 2+ level, the highest response to TGFβ-1 obtained with the long promoter construct suggested a critical and major contribution of ELK-1. As we showed in the present study that TGF-β1 increased SP1 and ELK-1 phosphorylation, we focused on the possible regulatory role of both SP1 and ELK-1 on the promoter constructs. In the presence of 1.25 mM eCa 2+ , we analyzed the effects of a 48 h overexpression of either Sp1, or Elk-1 or both in chondrocytes, electroporated with either the -720 bp or the -2715 bp fragments As depicted in Figure 7C , in chondrocytes transfected with the -720 bp fragment, overexpression of Elk-1 remained ineffective. In contrast, overexpression of Sp1 alone and in combination with Elk-1 induced the basal Firefly/Renilla ratio by 1.2-fold. Moreover, in chondrocytes electroporated with the -2715 bp construct, overexpression of Sp1 raised the basal luciferase ratio by 1.3-fold, while overexpression of Elk-1 elevated it by 1.8-fold ( Figure 7C ). Likewise, simultaneous overexpression of Sp1 and Elk-1 increased the basal Firefly/Renilla ratio until 2.6-fold. Finally, to further evaluate the respective contribution of SP1 and ERK1/2, we assessed the activity of Ank promoter constructs in chondrocytes challenged or not with TGF-β1 for 48 h after a 1 h pretreatment with WP631 or PD98059. As depicted in Figure 7D , the basal Firefly/Renilla ratios were unaffected by either inhibitor. In chondrocytes transfected with the -720 bp construct, the stimulating effect of TGF-β1 on the Ank promoter activity was reduced from 1.3-fold to 1.2-fold in the presence of WP631 or PD98059 ( Figure 7D ). This result confirmed that activation of SP1 was a downstream event of ERK1/2 activation, consistently with the data provided in Figure 6B . In chondrocytes transfected with the -2715 bp construct, the stimulating effect of TGF-β1 on the reporter activity was reduced from 2.7-fold to 2-fold and 1.55-fold in the presence of WP631 or PD98059 respectively ( Figure 7D ). The greater inhibitory potency of PD98059 supported the dual contribution of SP1 and ELK-1 to the control of Ank promoter by TGF-β1, consistently with the data obtained with overexpressing plasmids ( figure 7C ). These results demonstrate that calcium is a key regulator of activation of the Ank promoter by TGF-β1 in chondrocytes. This activation requires the phosphorylation of ERK1/2, which in turn activates the SP1 and ELK-1 transcription factors, where SP1 seems to behave as a transcriptional co-activator for ELK-1.
DISCUSSION
Although the clinical association between CCA and primary hyperparathyroidism was established 40 years ago (28) , a very few studies addressed the relationship between CPPD deposition and calcium levels in extracellular fluids. Recently, Volpe and colleagues demonstrated the high frequency of CCA in patients with familial hypocalciuric hypercalcemia and CCA (10) . However, the molecular mechanisms linking high Ca 2+ levels to CCA still needed to be elucidated.
As an increase in PTH-mid fragments was noticed in patients with CPPD crystal deposition disease (7), the possible influence of PTH on Ank and PC-1 expression was studied previously in our laboratory (Bianchi et al, unpublished observations). At that time, we failed to observe any difference between controls and PTHstimulated chondrocytes. This finding is consistent with a previous study having described the ineffectiveness of PTH on PC-1 enzymatic activity in human osteoblast-like cells (29) . Therefore, we focused our work on the regulation of the ePPi/Pi balance by TGF-β1, whose elevated synovial fluid levels were reported to be associated with CPPD formation in OA patients (30) .
In the present study, we paid first a special attention to the characterization of the articular phenotype of the chondrocytes. We confirmed the absence of TNAP mRNA, thus indicating that our evaluation of the ePPi levels throughout the study was not biased by its possible hydrolysis into ePi. As a consequence, no ePi accumulation could occur in the culture medium. This feature is critical, since ePi was also demonstrated to increase the TGF-β1-induced expression of Ank in chondrogenic cells (31) , a finding that we confirmed recently in articular chondrocytes supplemented with ePi (32). Moreover, ePi was previously shown to enhance the expression of matrix-gla protein in growth plate chondrocytes, thus inhibiting the mineralization process (33) . This suggests that ePi alone could orientate the chondrocyte phenotype towards a hypertrophic state, whereas we demonstrated previously that ePPi contributed to the maintenance of the differentiated chondrocyte phenotype (18) .
The present work demonstrates clearly that increasing eCa 2+ concentrations potentiated the TGF-β1-induced production of ePPi in a concentration-related fashion by increasing Ank and PC-1 expression. These results are consistent with the very recent work from Oca and colleagues who showed that the up-regulation of Ank by TGF-β1 was increased in the presence of a higher eCa 2+ level during chondrogenesis of the ATDC5 cell line (31) . However neither the dose-dependence to eCa 2+ concentration nor the deciphering of underlying signaling pathway implicated was performed. A possible regulation by calcium could occur by CaSR activation, which, however, failed to modify the TGF-β1-mediated ePPi production in our experimental conditions. This lack of efficiency of GdCl 3 was consistent with the differentiated phenotype of chondrocyte, since a strong expression of CaSR was reported in growth plate or hypertrophic chondrocytes rather than in articular chondrocytes (34) . Altogether, these findings demonstrated that the eCa 2+ pool modulated the control of the ePPi/ePi balance by TGF-β1, providing a possible mechanistic link between hypercalcemia and secondary CPPD deposition. In our experimental conditions, TGF-β1 provoked an entrance of eCa 2+ in chondrocytes, which depended on L-and T-VOCs. The eCa 2+ input was consistent with previous works having demonstrated a similar influx in other cell types, like fibroblasts (35) or vascular smooth muscle cells (36) . In the present study, the contribution VOCs was evaluated indirectly by their blockade with selective inhibitors, but there was a good correlation between the changes observed in cCa 2+ levels and ePPi levels in our study. The contribution of L-VOCs to TGF-β1-induced calcium entrance was shown recently in ATDC5 cells, although no contribution of T-VOCs was reported (31) . This was quite unexpected, since T-VOCs were shown to be expressed not only in primary chondrocytes, but also in the ATDC5 cell line (12) . Our data on cCa 2+ level support a major role for T-VOCs compared to L-VOCs. In contrast, ω-Agatoxin was unable to block the calcium influx in our experimental system, although a modest, probably Ca 2+ -independent effect was observed on ePPi levels and expression of Ank and PC-1. This result is in line with the current lack of demonstration that P/QVOCs are expressed in articular chondrocytes or in ATDC5 cells.
The link between IP 3 and calcium is welldescribed in chondrocytes, as other studies suggested (37) or demonstrated (38) an IP 3 -dependent calcium release from the internal stores, using hypotonic shock and fluid-flow experiments respectively. Noteworthy, in mesangial cells, TGF-β1 induced a calcium mobilization, which depended on both IP 3 release and the disruption of the actin cytoskeleton organization (39) . In our study, we used U73122, an inhibitor of PLC, which cleaves phosphatidylinositol-2-phosphate in IP 3 and diacylglycerol. We demonstrated that U73122 was ineffective on the TGF-β1-mediated calcium influx, supporting that this phenomenon was independent of IP 3 pathway in articular chondrocytes. Similar results were reported in chondrocytes in which a calcium influx was generated by an electrical stimulation (40) . Thus, the variable implication of IP 3 could depend on the nature of the stimulation used, i.e. localized voltage modifications vs. cell membrane stretches. TGF-β1 was also shown to modify the cell membrane voltage, by modulating K + currents in microglia cells (41) . Interestingly, rat articular chondrocytes express such K + channels (42) , suggesting that electrophysiological changes may have contributed to the observed IP 3 -independent mechanism. Altogether, these findings support the hypothesis of a quick TGF-β1-mediated modification of the K + currents, resulting in the opening of L-and T-VOCs, and secondary calcium influx into chondrocytes. This was already demonstrated in pituitary cells, where a variation in K + currents induced a LVOCs-dependent Ca 2+ influx (43) . Although ionomycin alone induced an increase in cytosolic calcium level in chondrocytes (calcium released from internal stores), addition of TGF-β1 further increased the Ca 2+ mobilization in our system. Therefore, the TGF-β1-induced production of ePPi is thought to depend rather on the availability of eCa 2+ pool than on intracellular stores. Indeed, we showed here that no significant calcium mobilization was detectable in the absence of eCa 2+ in the culture medium, and that cCa 2+ levels measured were higher in the presence of elevated eCa 2+ concentrations. Likewise, another work reported an exclusive dependency of the increase in aggrecan and type II collagen mRNA to the eCa 2+ reservoir was reported in electricallystimulated chondrocytes (40) .
We deciphered previously the signaling pathways activated by TGF-β1 responsible for Ank induction, and thus ePPi production by articular chondrocytes (5). These were Smadindependent, but relied on ERK1/2 and Ca 2+ -dependent PKCs. Oca and colleagues confirmed recently that the induction of Ank expression depended on activation of Ca 2+ -dependent PKCs (31) . We demonstrate here that ePPi production mostly depended upon the synergistic action of TGF-β1 and eCa 2+ input which both controlled the protein level of the transcription factor SP1. We also showed that TGF-β1-induced the phosphorylation of SP1 in a ERK1/2-dependent mechanism, as demonstrated by others for the regulation of the gastrin promoter (26) . TGF-β1 is often described as a biological agent promoting SP1 activity. For example, TGF-β1 enhanced the DNA-binding capacity of SP1 in trabecular bone-derived cells (44) , while promoting the SP1-dependent transcription of type I collagen in fibroblasts (45) . Calcium was also demonstrated to be critical for the ability of SP1 to stimulate the basal (14) and TGF-β1-induced expression of GlcAT-I (16) .
Our experiments underline that the calciumincreased effects of TGF-β1 on ePPi metabolism was supported by an enhanced activation of ERK1/2 and PKCα pathways. This is consistent with another study having shown the calciumdependency of ERK1/2 phosphorylation during the induction of the phosphate transporters Glvr-1 and -2 by Pi in odontoblasts (46) . Noteworthy, we demonstrated that the ability of eCa 2+ to potentiate the phosphorylation of ERK1/2 by TGF-β1 was likely supported by the activation of Ras, as the blockade of VOCs inhibited both Ras and ERK1/2 activation. These data are consistent with the contribution of the Ras/Raf-1 pathway to the stimulatory effect of TGF-β1 on Ank expression at a "physiological" (1.25 mM) free eCa 2+ level (5) , and the previous demonstration that eCa 2+ influxes could activate Ras, which is subsequently able to activate MEK1 and MAPK (47) . Such close relationship was further supported by the inability of TGF-β1 to activate Ras in the absence of eCa 2+ or after Ca 2+ chelation. Additionally, PKCs are well-described to directly activate ERK1/2 (48-50) and Ca 2+ -dependent PKCs are key regulators of Ank expression in chondrocytes. Taken together, these data support that a critical cytosolic Ca 2+ level must be reached to activate Ras, ERK1/2 and PKCα. Such a level is achieved at a physiological free eCa 2+ level, by a TGF-β1-dependent calcium influx through L-and TVOCs.
Finally, using two constructs of the Ank promoter, we demonstrated that the presence of the Elk-1 responsive element was indisputable for the inducing effect of TGF-β1. This finding corroborated the ERK1/2-dependent activation of ELK-1 by TGF-β1. A comparable signaling cascade was reported for the regulation of type I collagen expression in fibroblasts (51) , and after the stimulation of the human chondrosarcomaderived chondrocytic cell line HCS-2/8 by connective tissue growth factor stimulation (52) . Noteworthy, a synergistic action of ELK-1 and SP1 was detectable in our experimental conditions. One can suggest the formation of a transcription enhancer complex containing these two transcription factors, as observed during the lipopolysaccharide-induced expression of tumor necrosis factor-α in macrophages (53) . Therefore the cooperative effect between SP1 and ELK-1 could depend upon a direct protein-protein interaction, although Tsai and colleagues are rather in favour of an indirect interaction through a protein scaffold depending on CBP/p300 (53) .
To summarize, we show here that high extracellular calcium level strongly increase the TGF-β1-induced production of ePPi. This effect is due to an enhancement of Ank and PC-1 mRNA and protein expression. The underlying molecular mechanisms implicated include a TGF-β1-mediated calcium influx through L-and T-VOCs. These results in an elevation of SP1 level, the activation of Ras and the phosphorylation of ERK1/2 and PKCα, to enhance finally the transcriptional activity of ELK-1 and SP1 acting synergistically on Ank expression.
Our results provide for the first time a possible mechanistic explanation for the onset of CCA secondary to primary hyperparathyroidism. This could support the research of new therapeutic options, such as the use of calcimimetics. For example, Cinacalcet has proven to reduce biochemical parameters such as PTH and hypercalcemia in patients with primary or secondary hyperparathyroidism (54). However, clinical outcomes in CCA still need to be demonstrated. Calcimimetics target the CaSR, which remains very marginally expressed in articular cartilage (34) . Yet, we show here that articular chondrocytes are very responsive to high eCa 2+ level by producing ePPi. Therefore, modulation of calcium levels and/or entrance could be an interesting avenue of clinical research aiming at the prevention of secondary CCA. modulators on Ank promoter activity in TGF-β1-stimulated chondrocytes. Cells were electroporated either with the -720 bp or -2715 bp construct (firefly luciferase as reporter gene). Normalization was performed using TK-Renilla reporter gene. Data are expressed as the mean fold induction of firefly/renilla luciferase activity ratio ± SD (n=4). Statistically significant differences vs. vehicle are indicated as *: p<0.05, and vs. TGF-β1 condition as #: p<0.05. C, Influence of Sp1, Elk-1 and Sp1+Elk-1 overexpression on the basal activity of Ank promoter. Chondrocytes were transfected either with the -720 bp or -2715 bp construct, and co-transfected either with pCMV-Sp1 or pCMV-Elk-1 or both. Normalization was performed using TK-Renilla reporter gene. Data are expressed as the mean fold induction of firefly/renilla luciferase activity ratio ± SD (n=4). Statistically significant differences vs. empty vector-transfected cells are indicated as *: p<0.05, and vs. single construct-transfected cells as #: p<0.05. D, Influence of SP1 (WP631) or ERK1/2 (PD98059) blockade on the basal and calciuminduced activity of Ank promoter. Chondrocytes were transfected either with the -720 bp or -2715 bp construct. Normalization was performed using TK-Renilla reporter gene. Data are expressed as the mean fold induction of firefly/renilla luciferase activity ratio ± SD (n=4). Statistically significant differences vs. cells without TGF-β1 at 1.25 mM eCa 2+ are indicated as *: p<0.05, and vs. TGF-β1-stimulated cells as #: p<0.05. Cells were maintained for 24 h in medium containing 1.25 mM eCa 2+ prior experiments.
